Aurigene Pharmaceutical Services Limited’s Post

"I'm thrilled to share that I've completed [ "Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes " ] on edX! This course helped me gain valuable insights into [ effects of drugs on living organisms.] and expand my knowledge in [" Drug Development" ]. Looking forward to applying my new skills and expertise in my future endeavors! #MedChem2 #Pharmacodynamics #LigandBinding #ClinicalOutcomes #Molecular Pharmacology #Drug Discovery #Pharmacology #edX

The quest for new drugs faces a critical hurdle: the scarcity of effective and safe new chemical entities (NCEs). This article explores how de novo design, a groundbreaking field utilizing computational algorithms to generate novel drug candidates, tackles this challenge. Join the Drug Discovery Biology and Bioinformatics Strategy Meeting in Princeton or San Diego and deep dive into the world of de novo design: 👉 Uncover the potential of AI: Learn how algorithms are revolutionizing drug discovery. 👉 Master cutting-edge techniques: Gain insights into de novo design strategies and SPiDER, a powerful target prediction tool. 👉 Connect with leading experts: Network with researchers and accelerate innovation in this exciting field. 👉 Shape the future of drug development: Be part of the conversation that's driving the discovery of next-generation therapeutics. Don't miss this opportunity to propel the future of medicine! Register for the Drug Discovery Strategy Meeting today! Join the collaborative discussions in Princeton or San Diego! Register for Princeton - https://lnkd.in/grQ3cU7m Register for San Diego- https://lnkd.in/g6-cEjyr #DrugDiscovery #DeNovoDesign #AI #Bioinformatics #NextGenTherapeutics

Drug discovery struggles with a key challenge: a shortage of novel, effective, and safe chemical entities (NCEs). De novo molecular drug design tries to remedy that. https://lnkd.in/gzhAdQf9 #newchemicalentity #drugdiscovery #drugdevelopment #moleculardesign #denovo #receptors #ligands #selforganization #neuralnetworks #validation

Our preclinical pharmacokinetics/toxicokinetics services include: ➡ Determining the distribution and excretion of drug entities across all administration routes. ➡ Developing and utilizing novel delivery, tracer, and analytical methods. ➡ Combining cutting-edge bioanalytical chemistry and radioanalytical capabilities with expertise in exposure, biochemistry, toxicology, and pathology to optimize drug efficacy. Partner with Lovelace Biomedical for a smoother and more informed drug development journey. https://bityl.co/OK0p

The preclinical bioanalysis of #XDC drugs is not only a process of scientific exploration but also a challenge that requires exceptional skill and innovative thinking. #Preclinical bioanalysis is a complex, multidimensional, and multi-step process that requires comprehensive evaluation of a drug’s pharmacokinetics, immunogenicity, safety, and efficacy.

𝑻𝒉𝒆 𝒇𝒊𝒓𝒔𝒕 𝑨𝒄𝒂𝒅𝒆𝒎𝒊𝒄 𝑪𝒖𝒓𝒓𝒆𝒏𝒄𝒚 𝑰 𝒉𝒂𝒗𝒆 𝒆𝒂𝒓𝒏𝒆𝒅... 🪙 Our first book chapter, titled "𝐅𝐮𝐧𝐝𝐚𝐦𝐞𝐧𝐭𝐚𝐥 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡𝐞𝐬 𝐨𝐟 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 [𝐂𝐡𝐚𝐩𝐭𝐞𝐫 - 𝟏𝟐]" has been published in "𝐁𝐢𝐨𝐜𝐡𝐞𝐦𝐢𝐜𝐚𝐥 𝐚𝐧𝐝 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐥𝐨𝐠𝐲 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲"! 📚This chapter includes, drug discovery and development pipeline, examined basic approaches, computational drug discovery techniques, and the potential of drug repurposing. As the field of #drugdiscovery continues to evolve rapidly, the insights and methodologies outlined in this chapter remain highly relevant, bridging the gap between foundational principles and cutting-edge #advancements. A big Thank You to GOURAV RAKSHIT sir for giving me this opportunity and all the co-authors who really helped make this happen. 🙏🏻 #Learniverse #drugdiscovery #drugrepurposing #research #innovation #medicine #pharmacology #chemistry #publication #bookChapter --

👉WEBINAR: Want to explore how to bridge the translatability gap between in vitro, in vivo, and clinical outcomes in drug development? Join our next upcoming PhysioMimix® OOC webinar on Thursday 26th with Dr. Emily Richardson Lead Scientist and Alysha Bray, Toxicology Scientist at CN Bio to learn more. Key takeaways: ✔️Understand the challenges in translating preclinical drug research to clinical success ✔️Discover how MPS/OOC can enhance your drug discovery pipeline ✔️Learn about our PhysioMimix human and animal liver MPS ✔️Explore how these models provide greater clarity for predicting DILI risk ✍️Register now to secure your spot: https://lnkd.in/ezkqAfWe Thursday 26th September 3:00 pm UK (BST) 10:am (ET) #CNBioAt #ClinicalTranslation #OrganOnAChip #DILI #Hepatotoxicity

The #karyotyping market serves various end-users, including clinical and research laboratories, hospitals, pathology laboratories, pharmaceutical and biotechnology companies, academic research institutes, and others. Clinical labs utilize karyotyping for #geneticdiagnostics, while hospitals employ it for patient care. Pathology labs benefit for disease analysis, and pharmaceutical and biotech firms use it in drug development. Academic research institutes also contribute to advancements through karyotyping applications in genetic studies. To know more about the study, visit: https://lnkd.in/gQHhX_UN #DBMR #GeneticAnalysis #ChromosomalAnalysis #KaryotypeTechnology #DiagnosticInnovation #PrecisionMedicine #BiotechResearch #ClinicalGenetics #LabTechnologies #GenomicAnalysis #PathologySolutions #BiomedicalResearch #MolecularDiagnostics #HealthcareInnovation #GenomicMedicine #ResearchAdvancements #DBMRInsights

Fast drug candidate discovery with Hit Finding services At Eurofins Discovery, our AI-driven drug design, high-throughput screening (HTS), and fragment-based screening (FBS) expertise enable precise identification of biologically active compounds. Our tailored solutions include custom screening cascades, vast compound libraries, and cutting-edge biophysical tools to meet your discovery needs. Whether you're looking for rapid results or innovative methodologies, we offer validated, best-in-class services to identify promising hits with the potential to reach IND. Eurofins Discovery Solutions: • Access 10,000+ off-the-shelf assays, pharmacology tools, and compound libraries. • Expertise in designing custom screening cascades for rapid hit selection. • Multi-disciplinary support for early drug discovery and integrated solutions. Learn how we can accelerate your hit finding and hit-to-lead process. https://lnkd.in/gNBDUEbM #DrugDiscovery #HitFinding #EurofinsDiscovery

CYTOCON DB is InSysBio's tool to navigate across in vivo baseline levels. CYTOCON DB is designed for Quantitative Systems Pharmacology (QSP) modelers and scientists who deal with biomarker analysis. Information collected in the database enables them to save time typically spent for gathering and processing of literature and available data utilized for selection of plausible virtual patient (VP) population against ranges of cell and cytokines concentrations. There are more than 90000 concentrations in CYTOCON DB now! To experience CYTOCON DB or its Open version, please visit: https://lnkd.in/e9jUFZPC #qsp #modelingandsimulation #cytocon #database #biopharma #cytokines #pharmacometrics #biotech #biotechnology #pharmaceuticals #drugdevelopment #drugdiscovery